Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Clostridioides difficile Infection Deceleration: What Is Next?

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Innate immune responsiveness predicts enhanced cellular immunity and symptomatic disease after controlled human influenza infection.

Nature medicine·2026
Same author

Influenza coinfection inhibits control of mycobacterial infection in a human challenge model.

Nature communications·2026
Same author

Predicting trajectories of illness using RNA velocity of whole blood.

Nature communications·2026
Same author

VizCOM: A Novel Tool for Advanced Visualization and Analysis of Cardiac Optical Mapping Data.

Computing in cardiology·2026
Same author

Molecular epidemiology and clinical differentiation between <i>Clostridioides difficile</i> infection and colonization across three chicago medical centers.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2026

相关实验视频

Updated: Jun 14, 2025

Development of a Larval Zebrafish Infection Model for Clostridioides difficile
09:13

Development of a Larval Zebrafish Infection Model for Clostridioides difficile

Published on: February 14, 2020

6.3K

如何开发一个受控的人类感染模型,用于Clostridioides difficile.

Annefleur D O Hensen1, Maria J G T Vehreschild2, Dale N Gerding3

  • 1Leiden University Center for Infectious Diseases (LUCID), Leiden University Medical Center (LUMC), Leiden, The Netherlands.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
|August 30, 2024
PubMed
概括
此摘要是机器生成的。

为测试新的治疗方法,开发一种对Clostridioides difficile (C. difficile) 的受控人类感染模型至关重要. 专家们讨论了在创建一个安全有效的模式来打击C. difficile感染 (CDI) 的挑战.

关键词:
这是C. difficile.奇姆 奇姆 奇姆克洛斯特里迪奥伊德斯困难菌被控制的人类控制的人类.专家意见 专家意见人类挑战研究研究研究感染 感染 感染

更多相关视频

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.5K
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

38.7K

相关实验视频

Last Updated: Jun 14, 2025

Development of a Larval Zebrafish Infection Model for Clostridioides difficile
09:13

Development of a Larval Zebrafish Infection Model for Clostridioides difficile

Published on: February 14, 2020

6.3K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.5K
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

38.7K

科学领域:

  • 微生物学 微生物学
  • 免疫学 免疫学 免疫学
  • 传染性疾病 传染性疾病

背景情况:

  • 艰难菌 (C. difficile) 感染 (CDI) 是医院获得的腹的主要原因,复发率很高.
  • 抗生素耐药性和便微生物群移植 (FMT) 中未知的因素阻碍了有效的治疗.
  • 需要新的非抗生素策略来增强对CDI的殖民抵抗力和免疫反应.

研究的目的:

  • 为了建立一个控制人类感染模型 (CHIM) 毒性C. difficile.的框架.
  • 为了使新的治疗方法的测试和微生物群/免疫学点的识别CDI.
  • 解决与毒性C. difficile CHIM.相关的伦理,科学,后勤和生物安全挑战.

主要方法:

  • 国际专家在Inno4Vac组织的研讨会上召开会议,讨论开发C. difficile CHIM的挑战.
  • 确定的主要挑战包括创建具有轻度至中度症状的临床相关模型,确定最佳注射剂量,并了解抗生素预治疗方案.

主要成果:

  • 专家的共识强调,需要克服特定的挑战,以实现功能性的C. difficile CHIM.
  • 该模型旨在诱导轻度至中度的CDI症状,而不是严重的疾病.
  • 最佳C. difficile注射剂量和抗生素预处理参数对于模型开发至关重要.

结论:

  • 一个成功开发的C. difficile CHIM将促进对新的抗CDI产品的评估.
  • 该模型将为更深入地了解CDI病理生理学,病变发生和免疫学提供一个平台.
  • 该CHIM框架对于推进研究和开发针对C. difficile的有效干预措施至关重要.